Abstract:Rui Deng, * Juan Lu, * Xiong Liu, Xiao-Hong Peng, Jie Wang, Xiang-Ping Li Department of Otolaryngology-Head and Neck Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, People's Republic of China *These authors contributed equally to this work Correspondence: Xiang-Ping Li Department of Otolaryngology-Head and Neck Surgery, Nanfang Hospital, 1838 North of Guangzhou Avenue, Guangzhou, People's Republic of China Tel +86-20-61642001 Fax +86-20-87703645 Email li321162@qq.com Purpose: Tumour-associated macrophages (TAMs) are the most abundant immune cells in the tumor microenvironment and provide a barrier against the cytotoxic effector functions of T cells and natural killer (NK) cells. Recently, TAMs have become increasingly recognised as an attractive target in combination therapy with PD-1/PD-L1 immuno-checkpoint blockades (ICBs). However, the relationship between PD-L1 expression and TAMs remains unknown in nasopharyngeal carcinoma (NPC). Patients and Methods: A total of 212 NPC patients from Nanfang hospital were collected in this study. We evaluated the expression of PD-L1 in tumor cells, CD68 (pan-macrophages), and CD163 (M2-like macrophage) in NPC tissues using immunohistochemical (IHC) staining. Results: The positivity of PD-L1 on tumor cells was 61.3% (130/212). The infiltration densities of CD68+ cells and CD163+ cells in PD-L1-positive NPC tissues were significantly higher than those in PD-L1-negative NPC tissues ( P =0.0012 for CD68; P < 0.0001 for CD163). Logistic regression analysis showed that high densities of CD68+ macrophages and CD163+ TAMs were significantly associated with increased PD-L1 expression. Subgroup analyses demonstrated that a positive PD-L1 expression on tumor cells in combination with lower CD163+ TAMs density was significantly associated with favorable prognosis, whereas negative PD-L1 expression on tumor cells with higher CD163+ TAMs density was associated with worse prognosis. Conclusion: The PD-L1 expression in tumor cells was positively correlated with TAMs density in tumor microenvironment of NPC, suggesting TAMs as a new target for combination therapy to improve the response rate of ICBs in NPC treatment. Keywords: nasopharyngeal carcinoma, PD-L1, tumor-associated macrophage, prognosis, tumor microenvironment

Expression of Programmed Death Ligand-2 is associated with Prognosis in Nasopharyngeal Carcinoma Microenviroment

Expression of programmed death ligand-1 predicts poor outcome in nasopharyngeal carcinoma

Expression and Clinical Significance of Programmed Death Ligand 1 in Nasopharyngeal Carcinoma.

Prognostic Value of Programmed Cell Death Ligand-1 Expression in Nasopharyngeal Carcinoma: A Meta-Analysis of 1,315 Patients

High Soluble Programmed Death-Ligand 1 Predicts Poor Prognosis in Patients with Nasopharyngeal Carcinoma

Prognostic value of PD-L1 and Siglec-15 expression in patients with nasopharyngeal carcinoma

PD-1 High Expression Predicts Lower Local Disease Control in Stage IV M0 Nasopharyngeal Carcinoma

Lymphocyte activating gene 3 protein expression in nasopharyngeal carcinoma is correlated with programmed cell death-1 and programmed cell death ligand-1, tumor-infiltrating lymphocytes

Good prognostic factor in patients with nonmetastatic nasopharyngeal carcinoma: Programmed death ligand-1 expression in tumor cells

PD-L1 predicts poor prognosis for nasopharyngeal carcinoma irrespective of PD-1 and EBV-DNA load

PD-1 and PD-L1 in locoregionally advanced nasopharyngeal carcinoma: Substudy of a randomized phase III trial

Correlation of PD-L1 Expression of Tumor Cells with Survival Outcomes after Radical Intensity-Modulated Radiation Therapy for Non-Metastatic Nasopharyngeal Carcinoma

The clinical prognostic value of PD-L1 after concurrent chemoradiotherapy in Chinese nasopharyngeal carcinoma patients

Role of β-catenin in PD-L1 expression of nasopharyngeal carcinoma

Characterization of PD-L1 expression and immune cell infiltration in nasopharyngeal cancer

PD-L1 Expression is Highly Associated with Tumor-Associated Macrophage Infiltration in Nasopharyngeal Carcinoma

PD-L1 expression as a potential predictor of immune checkpoint inhibitor efficacy and survival in patients with recurrent or metastatic nasopharyngeal cancer: a systematic review and meta-analysis of prospective trials

Expression and clinical significance of PD-L1 and BRAF expression in nasopharyngeal carcinoma

Prognostic stratification of patients with nasopharyngeal carcinoma based on tumor immune microenvironment

Spatial architecture of regulatory T-cells correlates with disease progression in patients with nasopharyngeal cancer

PD-L2 Based Immune Signature Confers Poor Prognosis in HNSCC